FDA Approvals for Liver and Stomach Cancer Extend the Reach of Immunotherapy
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
Tag: liver cancer
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which immunotherapeutics...
On Thursday, the U.S. Food and Drug Administration (FDA) expanded the use of the antiangiogenic therapeutic regorafenib (Stivarga) to...
Liver cancer rates have been on the rise in the United States and have tripled in the last four...